CHF treatment devices market seen reaching $30.07 billion by 2030

The Business Research Company says the global market for congestive heart failure treatment devices is projected to grow from $21.07 billion in 2025 to $30.07 billion by 2030, driven by rising cardiovascular disease, aging populations and wider use of implantable and mechanical support devices. North America led the market in 2025, while Asia-Pacific is expected to grow the fastest.

Why it matters: - Congestive heart failure treatment devices are becoming more important as heart disease cases rise worldwide and health systems look for ways to reduce hospital admissions. - The market’s projected climb to $30.07 billion by 2030 signals continued demand for implanted devices, monitoring tools and mechanical circulatory support.

What happened: - The Business Research Company released a 2026 market report on congestive heart failure treatment devices with a forecast through 2035. - The report estimates the market will grow from $21.07 billion in 2025 to $22.76 billion in 2026. - The report projects a compound annual growth rate of 8.0% in 2026. - The market is forecast to reach $30.07 billion by 2030, with a CAGR of 7.2%. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The company offers a free sample of the report. - The company also offers the full market report.

The details: - The report links historical growth to rising congestive heart failure prevalence, more cardiovascular disease cases, wider use of implantable cardiac devices, more specialized cardiac care centers and better survival rates. - The forecast is supported by an aging population, stronger demand for minimally invasive cardiac interventions and greater focus on early disease management. - The report also points to broader access to advanced heart failure therapies in emerging economies. - Long-term mechanical circulatory support devices are expected to gain more use. - The report identifies growth in sophisticated implantable devices as a key trend. - Ventricular assist systems are becoming more important for advanced heart failure care. - Efforts to cut heart-failure readmissions are increasing. - Continuous cardiac monitoring and management tools are drawing more interest. - Congestive heart failure treatment devices are designed to support the management of CHF, a condition in which the heart pumps less efficiently and fluid accumulates in the lungs and other tissues. - These devices monitor cardiac function, improve heart performance and reduce complications. - The devices are intended to improve quality of life and help prevent further deterioration. - Rising cardiovascular disease prevalence remains a major driver of market growth. - Cardiovascular disorders include coronary artery disease, hypertension and heart failure. - The report links rising cardiovascular disease to obesity, sedentary lifestyles, poor nutrition and aging populations. - A US Centers for Disease Control and Prevention report released in October 2024 said cardiovascular disease caused 919,032 deaths in the US in 2023. - The CDC said that represented one in every three US deaths. - The CDC said coronary heart disease remained the most common cardiovascular condition. - The CDC said about one in six cardiovascular deaths occurred among adults younger than 65.

Between the lines: - The report’s emphasis on readmission reduction and continuous monitoring suggests the market is shifting beyond treatment toward long-term management. - The combination of aging demographics and higher chronic disease burden points to sustained demand, not a short-term spike. - The regional outlook suggests mature markets still dominate spending, but growth is moving faster where access to advanced cardiac care is expanding.

What's next: - The market is expected to keep expanding as clinicians adopt more implantable and mechanical support technologies. - Emerging economies are likely to become more important as access to advanced therapies improves. - The company’s 2026 reports also add market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspot infographics and updated trend analysis. - More information is available through the company’s report links and social channels.